Metformin may directly inhibit pathway related to cancer invasion and migration, including AMP-activated protein kinase (AMPK), epithelial-mesenchymal transition (EMT), VEGF and mammalian target of rapamycin (mTOR) [102], thus inhibiting cancer cell progression [103]. This evidence concerns the gene VEGFA and cancer.